Physician
Psychiatry
Dr. Robert A. Robinson, MD
|
|
Give Review
Doctor Robert A. Robinson, MD is an expert in the field of Psychiatry. He went to medical school at Weill Cornell Medical College of Cornell University. Weill Cornell Medical College of Cornell University has a rank of 18 in research and a 49 in primary care Robert Robinson is also a published doctor. He has 84 publication published. The most recent publication is: A Randomized, Placebo-Controlled, Double-Blind Efficacy Study of Nefiracetam to Treat Poststroke Apathy. He accepts Medicare payments and is listed with Medicare.gov.
Publications
- A Randomized, Placebo-Controlled, Double-Blind Efficacy Study of Nefiracetam to Treat Poststroke Apathy.
- Mortality in Patients With Traumatic Brain Injury.
- Results of the citalopram to enhance cognition in Huntington disease trial.
- Incident apathy during the first year after stroke and its effect on physical and cognitive recovery.
- Prevention of poststroke apathy using escitalopram or problem-solving therapy.
- Evolving research in the geriatric neuropsychiatry of stroke.
- Emotional blunting following left basal ganglia stroke: The role of depression and fronto-limbic functional alterations.
- Improving Recovery After Stroke: A Role for Antidepressant Medications?
- Stroke.
- Treatment of late-life depression: a role of non-invasive brain stimulation techniques.
- Increased Frequency of First-Episode Poststroke Depression After Discontinuation of Escitalopram.
- Diagnostic criteria for depression in Parkinson's disease: A study of symptom patterns using latent class analysis.
- Diagnostic criteria for depression in Alzheimer disease: a study of symptom patterns using latent class analysis.
- Altered neural activity and emotions following right middle cerebral artery stroke.
- Effect of Antidepressants on the Course of Disability Following Stroke.
- Selective serotonin-reuptake inhibitors and recovery after stroke.
- How should depression be diagnosed in patients with stroke?
- The frequency, clinical correlates, and mechanism of anosognosia after stroke.
- Apathy following stroke.
- Poststroke depression: a review.
- Neuropsychiatric disorders following stroke.
- Escitalopram and enhancement of cognitive recovery following stroke.
- Subgenual cingulate theta activity predicts treatment response of repetitive transcranial magnetic stimulation in participants with vascular depression.
- Limbic metabolic abnormalities in remote traumatic brain injury and correlation with psychiatric morbidity and social functioning.
- Top cited papers in international psychogeriatrics: 5. A controlled study of repetitive transcranial magnetic stimulation as a treatment of depression in the elderly.
- Disease outcome, alexithymia and depression are differently associated with serum IL-18 levels in acute stroke.
- Citalopram for continuation therapy after repetitive transcranial magnetic stimulation in vascular depression.
- Prevention of first-episode depression: progress and potential.
- Is family history of depression a risk factor for poststroke depression? Meta-analysis.
- Incomplete financial disclosure in a study of escitalopram and problem-solving therapy for prevention of poststroke depression.
- Double-blind treatment of apathy in patients with poststroke depression using nefiracetam.
- Frequency and correlates of involuntary emotional expression disorder in Parkinson's disease.
- Decreased heart rate variability is associated with poststroke depression.
- Aging and alexithymia: association with reduced right rostral cingulate volume.
- Escitalopram and problem-solving therapy for prevention of poststroke depression: a randomized controlled trial.
- Unawareness of illness in neuropsychiatric disorders: phenomenological certainty versus etiopathogenic vagueness.
- A validation study of depressive syndromes in Parkinson's disease.
- Treatment of vascular depression using repetitive transcranial magnetic stimulation.
- Neural bases of dysphoria in early Huntington''s disease.
- Correlation between denial of illness and executive function following stroke: a pilot study.
- Nondysphoric depression following stroke.
- Double-blind randomized treatment of poststroke depression using nefiracetam.
- In vivo proton magnetic resonance spectroscopy in patients with mood disorders: a technically oriented review.
- Aging, grey matter, and blood flow in the anterior cingulate cortex.
- The cerebellum and emotional experience.
- Effect of antidepressant therapy on executive function after stroke.
- Neuropsychological correlates of normal variation in emotional response to visual stimuli.
- Neuropsychological performance is associated with vascular function in patients with atherosclerotic vascular disease.
- The construct of generalized anxiety disorder in Alzheimer disease.
- Risk factors for and correlates of poststroke depression following discontinuation of antidepressants.
- Primary mania versus secondary mania of HIV/AIDS in Uganda.
- Phenomenology and clinical correlates of delusions in Alzheimer disease.
- Aggressive behavior in patients with stroke: association with psychopathology and results of antidepressant treatment on aggression.
- Defining and diagnosing involuntary emotional expression disorder.
- Response of emotional unawareness after stroke to antidepressant treatment.
- The construct of minor and major depression in Alzheimer's disease.
- Mood disorders in the medically ill: scientific review and recommendations.
- Alcohol misuse and mood disorders following traumatic brain injury.
- Community development model for public health applications: overview of a model to eliminate population disparities.
- White matter volume and cognitive dysfunction in early Huntington's disease.
- Discovering the full spectrum of cardiovascular disease: Minority Health Summit 2003: report of the Advocacy Writing Group.
- Vascular depression and poststroke depression: where do we go from here?
- Blood vessel function and cognition in elderly patients with atherosclerosis.
- Responses to S. Leonard Syme's essay.
- Repetitive transcranial magnetic stimulation as treatment of poststroke depression: a preliminary study.
- The marketing of menthol cigarettes in the United States: populations, messages, and channels.
- Menthol cigarettes: setting the research agenda.
- Eliminating tobacco-related health disparities: directions for future research.
- Major depression following traumatic brain injury.
- Pathological laughing and crying following traumatic brain injury.
- Mood disorders following traumatic brain injury.
- Mortality and poststroke depression: a placebo-controlled trial of antidepressants.
- The effect of early versus late antidepressant treatment on physical impairment associated with poststroke depression: is there a time-related therapeutic window?
- Poststroke depression: prevalence, diagnosis, treatment, and disease progression.
- Does cognitive recovery after treatment of poststroke depression last? A 2-year follow-up of cognitive function associated with poststroke depression.
- Treatment of poststroke generalized anxiety disorder comorbid with poststroke depression: merged analysis of nortriptyline trials.
- Regional cerebral blood flow changes during visually induced subjective sadness in healthy elderly persons.
- Clinical correlates of aggressive behavior after traumatic brain injury.
- Phenomenological characteristics of poststroke depression: early- versus late-onset.
- Stroke-related depression.
- Comparison of cognitive impairment associated with major depression following stroke versus traumatic brain injury.
- Preventing poststroke depression: a 12-week double-blind randomized treatment trial and 21-month follow-up.
- Longitudinal course of mood disorders following traumatic brain injury.
Schools
University of Missouri Kansas City Campus
Weill Cornell Medical College
Mayo Grad School MedMayo Fndn
Doctors Specialties
- Anatomic Pathology
- Psychiatry
Accepted Insurances
Education
-
Johns Hopkins University -
Albert Einstein - Montefiore Medical Center -
Weill Cornell Medical College of Cornell University
Drug Facts
| NPI NUMBER | 1295720944 | |
| NPPES Provider LastName | ROBINSON | |
| NPPES Provider FirstName | ROBERT | |
| NPPES Provider ZIPCode | 522421009 | |
| NPPES Provider State | IA | |
| Specialty Description | Psychiatry | |
| Total Claim Count | 32.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1184612988 |
| Last Name Of The Provider | ROBINSON |
| First Name Of The Provider | ROBERT |
| View All |
Similar Doctors
|
|
Dr. Christopher A. Welsh, MD |
|
|
Dr. Kathryn E. Gilligan, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Raymond R. Crowe, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Robert T. Cook, MD |
|
|
Dr. John D. Kemp, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jo A. Benda, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Robin C. Kopelman, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Betsy K. McGee, MD |
|
|
Dr. Anthony C. Miller, MD |
|
|
Dr. Aaron J. Kauer, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Evan Ouyang, MD |
|
|
Dr. Barry R. Deyoung, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Danniele G. Holanda
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Lubomir P. Turek, MD |